Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
News Release
Genex Services' IME Program Earns URAC designation
Company among first to receive new certification status for independent medical exams WAYNE, PA –
Workers' Comp
Article
WorkCompWire: 5 Things You Should Know about IMEs and COVID-19
Though the COVID-19 pandemic has presented many challenges, workers’ compensation (WC) programs have continued to push claims forward – often with
Auto Casualty
Article
WorkCompWire: 5 Things You Should Know about IMEs and COVID-19
Though the COVID-19 pandemic has presented many challenges, workers’ compensation (WC) programs have continued to push claims forward – often with
Mitchell
Article
Workers’ Comp Data: About 25% of COVID-19 Claims Have Associated Medical Costs
Data analysis by Aarthi Thiruvengadam. In 2020, the workers’ compensation industry endured many changes due to the COVID-19 pandemic, incl
Mitchell
News Release
Mitchell’s Q1 Industry Trends Report Examines the Ongoing Effects of COVID-19 and Implications for Property & Casualty Claims and Collision Repair
SAN DIEGO, CA—Mitchell, a leading provider of technology, connectivity and information solutions to the Property &
Auto Casualty
Article
Drug of the Month: Insights Into COVID-19 Vaccines and Workers' Comp
COVID-19 vaccination efforts continue to progress, after the